Author

Fedor L. Bezrukov

University of GenevaORCID 0000-0003-3601-1003Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alice SalibiD· 1 shared Antoine de WeckiD· 1 shared Chelsea MayohiD· 1 shared Emmy D.G. FleureniD· 1 shared Greg M. ArndtiD· 1 shared Ian P. StreetiD· 1 shared Marie WongiD· 1 shared Mohamed FarehiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice SalibORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 21, 2026

METTL1 gene dosage and catalytic activity define a targetable vulnerability in pediatric cancers

Pei Yan Liu, Steven He, Olesya O. Panasenko…·Paul G. Ekert

This study identifies METTL1 gene dosage and catalytic activity as therapeutic targets in pediatric cancers, showing that inhibiting METTL1 synergizes with BCL-xL inhibitors.

DOI 10.64898/2026.10.20.760582

humanexperimental assay

𝕏 PostBluesky